As of Feb 17
| +0.41 / +1.81%|
The 1 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 105.00, with a high estimate of 105.00 and a low estimate of 105.00. The median estimate represents a +356.52% increase from the last price of 23.00.
The current consensus among 1 polled investment analysts is to Buy stock in Albireo Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.